By Business/Source
Currency:EUR
2026/Q1
Stock NameRevenueRatio
Imaging2.8B51.76%
Precision Therapy1.6B29.69%
Diagnostics985M18.23%
Reconciliation to consolidated financial statements17M0.31%
By Country/Region
Currency:EUR
2023/FY
Stock NameRevenueRatio
United States7.51B34.62%
Europe, Commonwealth of Independent States, Africa, and Middle East (EMEA)5.93B27.33%
Asia Pacific, Japan3.01B13.88%
China2.82B13.01%
Americas1.36B6.26%
Germany1.06B4.90%
View all